GlassScriptPhysician profile
Lara N King
NPI 1679857932
$7,862.93
in general payments reported to CMS, 2019-2025
18 companies · $4,502 in 2025
The $4,502 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,505 · 2022: $1,203 · 2024: $653 · 2025: $4,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,700 · Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,700.00 |
| Food and Beverage | $1,454.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $3,752.50 | 2021-2025 | Omnipod, Omnipod |
| Astrazeneca Pharmaceuticals LP | $1,332.27 | 2021-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $475.00 | 2021-2025 | Ozempic |
| Lilly USA, LLC | $444.99 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $426.12 | 2021-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $360.21 | 2022-2025 | |
| Abbott Laboratories | $287.58 | 2021-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $241.66 | 2025 | Korlym |
| Amgen INC. | $152.79 | 2021-2022 | |
| Medtronic, INC. | $106.24 | 2022-2025 | Minimed 780g |
| Merck Sharp & Dohme LLC | $103.86 | 2021-2022 | |
| Dexcom, INC. | $52.96 | 2021-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $34.97 | 2024 | |
| Averitas Pharma INC. | $24.19 | 2025 | Qutenza |
| Tandem Diabetes Care, INC. | $20.91 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $17.80 | 2025 | Posluma |
| Grt US Holding, INC. | $14.92 | 2022 | |
| Valinor Pharma, LLC | $13.96 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lara King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.